• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Fact Sheet

Articles Tagged with ''Fact Sheet''

Fact Sheet

Dementia Treatment Algorithm

December 31, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Dementia Treatment Algorithm




Read More
1764161289276.jpeg

Fast Practical Psychiatry For Busy Clinicians

December 20, 2025
Daniel Carlat, MD

Busy clinicians don’t need more noise, they need clarity. That’s the idea behind the new Carlat Fact Sheet Web App: fast, searchable psychiatry you can actually use.




Read More
Clinical Guidance

Depressive Disorders Treatment Algorithm

November 24, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • Depressive Disorders Treatment Algorithm





  • Read More
    Clinical Guidance

    Depressive Disorders General Prescribing Tips

    November 24, 2025
    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

    Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

  • For patients who are antidepressant-naïve (admittedly rare in psychiatric practice), choose something effective with minimal side effects.




  • Read More
    Clinical Guidance

    Recommended Labs for Psychiatric Medications

    November 19, 2025
    Daniel Carlat, MD and Victoria Hendrick, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    This fact sheet outlines our approach to ordering lab tests for psychiatric inpatients.




    Read More
    Fact Sheet

    Iloperidone (Fanapt) Fact Sheet for General Psychiatry

    November 19, 2025
    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

    Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Iloperidone is not recommended as a first-choice antipsychotic due to twice-daily dosing, slow titration requirements, QT prolongation (similar to ziprasidone), dizziness, moderate weight gain, increased blood sugar, and overall weaker efficacy compared to other agents.


    Read More
    Clinical Guidance

    Choosing and Managing Benzodiazepines

    November 19, 2025
    Daniel Carlat, MD and Victoria Hendrick, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Benzodiazepines can be a tricky class of medications to manage, especially in inpatient settings where patients may have complex needs or a history of substance use.




    Read More
    Fact Sheet

    Paliperidone (Invega) Fact Sheet [G] for General Psychiatry

    November 19, 2025
    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

    Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Paliperidone is the active metabolite of risperidone.


    Read More
    Fact Sheet

    Fluphenazine (Prolixin) Fact Sheet [G]

    November 19, 2025
    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

    Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Fluphenazine is an effective, inexpensive first-generation antipsychotic (FGA) with a long history of use, but its utility is limited in some patients due to extrapyramidal symptoms (EPS) and the risk of tardive dyskinesia.


    Read More
    Fact Sheet

    Nefazodone (Serzone) Fact Sheet [G]

    November 18, 2025
    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

    Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Nefazodone was once popular due to its low rate of sexual side effects, but its use has dramatically declined because of rare yet serious hepatic toxicity.


    Read More
    Previous 1 2 … 13 14 15 16 17 18 19 20 21 … 56 57 Next
    Try The New AskCarlat AI

    Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

    Available In The Carlat Toolkit
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB8e_SpiralCover.png

      Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

      Updated 2026 prescriber's guide.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2782224449.jpg
      General Psychiatry

      Gender Affirming Care: Fall of the House of Hopkins

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.